[Federal Register Volume 78, Number 207 (Friday, October 25, 2013)]
[Notices]
[Pages 63969-63970]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-25178]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Defense Health Board; Notice of Federal Advisory Committee 
Meeting

AGENCY: Department of Defense (DoD).

ACTION: Notice of Federal Advisory Committee meeting.

-----------------------------------------------------------------------

SUMMARY: The Department of Defense is publishing this notice to 
announce that the following Federal Advisory Committee meeting of the 
Defense Health Board will take place.

DATES: 

Monday, November 18, 2013

8:00 a.m.-8:45 a.m. (Administrative Working Meeting)
9:00 a.m.-12:00 p.m. (Open Session)
12:00 p.m.-1:00 p.m. (Administrative Working Meeting)
1:00 p.m.-5:30 p.m. (Open Session)

Tuesday, November 19, 2013

7:15 a.m.-1:30 p.m. (Administrative Working Meeting)

ADDRESSES: Defense Health Headquarters (DHHQ), Pavilion Salons B-C, 
7700 Arlington Blvd., Falls Church, Virginia 22042 (escort required; 
see guidance in SUPPLEMENTARY INFORMATION, ``Public's Accessibility to 
the Meeting.'')

FOR FURTHER INFORMATION CONTACT: The Director of the Defense Health 
Board is Ms. Christine Bader, 7700 Arlington Boulevard, Suite 5101, 
Falls Church, Virginia 22042, (703) 681-6653, Fax: (703) 681-9539, 
[email protected]. For meeting information, please contact Ms. 
Kendal Brown, 7700 Arlington Boulevard, Suite 5101, Falls Church, 
Virginia 22042, [email protected], (703) 681-6670, Fax: (703) 
681-9539.

SUPPLEMENTARY INFORMATION: This meeting is being held under the 
provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C., 
Appendix, as amended), the Government in the Sunshine Act of 1976 (5 
U.S.C. 552b, as amended), and 41 CFR 102-3.150, and in accordance with 
section 10(a)(2) of Public Law. Additional information, including the 
agenda and electronic registration, is available at the DHB Web site, 
http://www.health.mil/dhb/meeting-2013-11-1819.cfm.
    Purpose of the Meeting: The purpose of the meeting is to address 
and deliberate pending and new issues before the Board.
    Agenda: Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102-3.140 
through 102-3.165 and subject to availability of space, the DHB meeting 
is open to the public from 9:00 a.m. to 12:00 p.m. and 1:00 p.m. to 
5:30 p.m. on November 18, 2013. On November 18, 2013, the DHB will 
receive briefings from the Department to include concussive care in 
theater, DoD's suicide prevention efforts, DoD Pharmaceutical 
Operations, and the Millennium Cohort Study with an overview of its 
findings. The Board will vote on proposed recommendations regarding the 
trends in overweight and obesity in America for the DoD. Additionally, 
the Board will receive briefings on the progress being made by the 
subcommittees on dual loyalties of military medical providers, the 
sustainment and advancement of amputee care, deployment pulmonary 
health, theater trauma lessons learned and Continuing Health Education.
    Public's Accessibility to the Meeting: Pursuant to 5 U.S.C. 552b, 
as amended, and 41 CFR 102-3.140 through 102-3.165 and subject to 
availability of space, this meeting is open to the public. Seating is 
limited and is on a first-come basis. All members of the public who 
wish to attend the public meeting must contact Ms. Kendal Brown at the 
number listed in the section FOR FURTHER INFORMATION CONTACT no later 
than noon on Friday, November 8 to register and make arrangements for a 
DHHQ escort, if necessary. Public attendees requiring escort should 
arrive at the DHHQ Visitor's Entrance with sufficient time to complete 
security screening no later than 8:30 a.m. on November 18. To complete 
security screening, please come prepared to present two forms of 
identification and one must be a picture identification card.
    Special Accommodations: Individuals requiring special 
accommodations to access the public meeting should contact Ms. Kendal 
Brown at least five (5) business days prior to the meeting so that 
appropriate arrangements can be made.
    Written Statements: Any member of the public wishing to provide 
comments to the DHB may do so in accordance with 41 CFR 102-3.105(j) 
and 102-3.140 and section 10(a)(3) of the Federal Advisory Committee 
Act, and the procedures described in this notice.
    Individuals desiring to provide comments to the DHB may do so by 
submitting a written statement to the DHB Designated Federal Officer 
(DFO) (see FOR FURTHER INFORMATION CONTACT). Written statements should 
address the following details: the issue, discussion, and a recommended 
course of action. Supporting documentation may also be included, as 
needed, to establish the appropriate historical context and to provide 
any necessary background information.
    If the written statement is not received at least five (5) business 
days prior to the meeting, the DFO may choose to postpone consideration 
of the statement until the next open meeting.
    The DFO will review all timely submissions with the DHB President 
and ensure they are provided to members of the DHB before the meeting 
that is subject to this notice. After reviewing the written comments, 
the President and the DFO may choose to invite the submitter to orally 
present their issue during an open portion of this meeting or at a 
future meeting. The DFO, in consultation with the DHB President, may 
allot time for members of the public to present their issues for review 
and discussion by the Defense Health Board.


[[Page 63970]]


    Dated: October 22, 2013.
Aaron Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2013-25178 Filed 10-24-13; 8:45 am]
BILLING CODE 5001-06-P